WCM Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-185,273
| Closed | -$1.87M | – | 216 |
|
|
2022
Q4 | $1.87M | Sell |
185,273
-2,366
| -1% | -$23.9K | 0.01% | 188 |
|
|
2022
Q3 | $4.19M | Buy |
187,639
+9,086
| +5% | +$203K | 0.02% | 150 |
|
|
2022
Q2 | $4.44M | Buy |
178,553
+65,173
| +57% | +$1.62M | 0.02% | 152 |
|
|
2022
Q1 | $4.4M | Buy |
113,380
+12,452
| +12% | +$483K | 0.01% | 152 |
|
|
2021
Q4 | $5.91M | Buy |
100,928
+7,307
| +8% | +$428K | 0.01% | 149 |
|
|
2021
Q3 | $5.55M | Buy |
93,621
+501
| +0.5% | +$29.7K | 0.01% | 147 |
|
|
2021
Q2 | $8.08M | Buy |
93,120
+3,696
| +4% | +$321K | 0.02% | 130 |
|
|
2021
Q1 | $7.37M | Sell |
89,424
-4,765
| -5% | -$393K | 0.02% | 128 |
|
|
2020
Q4 | $8.57M | Sell |
94,189
-30,999
| -25% | -$2.82M | 0.02% | 125 |
|
|
2020
Q3 | $5M | Buy |
125,188
+7,461
| +6% | +$298K | 0.02% | 134 |
|
|
2020
Q2 | $4.04M | Buy |
117,727
+4,253
| +4% | +$146K | 0.02% | 137 |
|
|
2020
Q1 | $2.52M | Buy |
113,474
+32,823
| +41% | +$729K | 0.01% | 142 |
|
|
2019
Q4 | $1.58M | Buy |
+80,651
| New | +$1.58M | 0.01% | 151 |
|